by Pawel Slusarczyk, President of the Board, CD3D Sp. z o.o.
- Introduction: short history of CD3D and The Open Bioprinting Cluster
- The historical approach: the development of the 3D printing industry and perspectives for the development of the bioprinting market
- Three pillars of technology development: the meaning of hardware, materials and software for creation of new kind of medical applications
What drives you?
The idea that I can make something no one did before
Why should the delegate attend your presentation?
They will probably hear something that they do not expect and will not hear from anyone else
What emerging technologies/trends do you see as having the greatest potential in the short and long run?
3D printing technology with use of brand new materials in liquid or semi-liquid form
What kind of impact do you expect them to have?
Possibility to create applications with completely new physical properties (soft, durable, biocompatibiles, biocompatible etc.)
What are the barriers that might stand in the way?
The usual suspects: time and money
It has to start somewhere. It has to start somehow. What better place than this? What better time than now?
About Pawel Slusarczyk
President of the board of CD3D Sp. z o.o. and Project Director at CD3D Medical. He has 15 years of business experience. One of the main animators of the Polish 3D printing industry, associated with it since January 2013. Creator of Centrum Druku 3D – one of the longest operating medium dedicated to additive manufacturing in Europe. Co-founder of the Open Bioprinting Cluster in Bionanopark in Lodz, Poland. Co-founder of SKAFFOSYS – the first Polish commercial bioprinter.
About CD3D Sp. z o.o.
CD3D is one of the most well-known companies operating on the 3D printing market in Poland. It has been operating since January 2013, ie since the launch of the “Centrum Druku 3D” portal – the largest medium dedicated additive manufacturing in the country. CD3D Medical offers services in the field of biomedical engineering and research in the field of biology and 3D printing. The heart of the project is a cluster of more than 20 bioprinters – SKAFFOSYS, which can be used to carry out research and scientific experiments using the bioprinitng method. CD3D Medical also usies other 3D printing technologies (FDM / SLA / DMP / MJF) for the production of prosthetic and anatomical models.